PRQR

ProQR Therapeutics N.V

May 19 • 01:41PM ET

1.47

-0.04 -2.65 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: WVE QURE ARWR EDIT VYGR

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	32.21%	Shs Outstand	105.36M	Perf Week	-8.13%
Market Cap	154.89M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	-20.11%
Enterprise Value	77.23M	PEG	-	EPS next Q	-0.15	Inst Own	34.02%	Short Float	1.18%	Perf Quarter	-1.34%
Income	-52.71M	P/S	9.97	EPS this Y	-28.50%	Inst Trans	-0.86%	Short Ratio	1.54	Perf Half Y	-32.26%
Sales	15.53M	P/B	3.58	EPS next Y	-15.80%	ROA	-37.92%	Short Interest	0.84M	Perf YTD	-27.23%
Book/sh	0.41	P/C	1.66	EPS next 5Y	9.59%	ROE	-81.98%	52W High	3.10 -52.58%	Perf Year	-14.04%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-98.02%	52W Low	1.33 10.53%	Perf 3Y	-21.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	79.71%	Volatility	7.37% 8.53%	Perf 5Y	-77.14%
Dividend TTM	-	EV/Sales	4.97	EPS Y/Y TTM	-44.36%	Oper. Margin	-346.94%	ATR (14)	0.13	Perf 10Y	-59.95%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	-23.73%	Profit Margin	-339.39%	RSI (14)	40.08	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	-47.57%	SMA20	-7.66%	Beta	0.06	Target Price	8.97
Payout	-	Debt/Eq	0.36	Sales Q/Q	-49.99%	SMA50	-12.37%	Rel Volume	0.69	Prev Close	1.51
Employees	-	LT Debt/Eq	0.24	Earnings	May 12 BMO	SMA200	-25.68%	Avg Volume	547.61K	Price	1.47
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.12% -54.37%	Trades		Volume	250,757	Change	-2.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)